Theodora Hadjistilianou

University of Siena

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Medical Imaging Medical Imaging professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Milo van Hoefen Wijsard

VU University Medical Center

NETHERLANDS

View details

Marco Mandalà

University of Siena

ITALY

View details

Michael Capra

Consultant Paediatric Oncologist, Clinical Professor - Trinity College Dublin

IRELAND

View details

Petra Ketteler

Universität Duisburg-Essen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Theodora Hadjistilianou

Research Interests

Explore related searches

Contact this professor

Articles (10)

Novel retinal finding in a patient with 4q12 deletion

Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG).

Incidence of Retinoblastoma Has Increased: Results from 40 European Countries.

13q deletion syndrome involving rb1: Characterization of a new minimal critical region for psychomotor delay

Bilateral retinoblastoma and osteogenesis imperfecta, a very rare association: Two cases

Fovea-sparing coats disease: A rare clinical entity

Medulloephitelioma in newborn: Advanced clinical status

Retinoblastoma is characterized by a cold, CD8+ Cell Poor, PD-L1− microenvironment, which turns into hot, CD8+ cell rich, PD-L1+ after chemotherapy

Spondyloocular Syndrome: A Novel XYLT2 Variant with Description of the Neonatal Phenotype

The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy

Collaborators (4)

Milo van Hoefen Wijsard

Marco Mandalà

Michael Capra

Petra Ketteler

Make your next move.